Docallopu

Docallopu may be available in the countries listed below.

Ingredient matches for Docallopu

Allopurinol

Allopurinol is reported as an ingredient of Docallopu in the following countries:

• Belgium

International Drug Name Search

Tantum Rosa

Tantum Rosa may be available in the countries listed below.

Ingredient matches for Tantum Rosa

Benzydamine

Benzydamine hydrochloride (a derivative of Benzydamine) is reported as an ingredient of Tantum Rosa in the following countries:

• Austria


• Bulgaria


• Georgia


• Germany


• Hungary


• Lithuania


• Poland


• Romania


• Russian Federation


• Serbia

International Drug Name Search

Butalone

Butalone may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Butalone

Phenylbutazone

Phenylbutazone is reported as an ingredient of Butalone in the following countries:

• Australia

International Drug Name Search

Asmoval

Asmoval may be available in the countries listed below.

Ingredient matches for Asmoval

Astemizole

Astemizole is reported as an ingredient of Asmoval in the following countries:

• Taiwan

International Drug Name Search

Atorvastatin Orion

Atorvastatin Orion may be available in the countries listed below.

Ingredient matches for Atorvastatin Orion

Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Atorvastatin Orion in the following countries:

• Finland

International Drug Name Search

Risedronate Delayed-Release Tablets

Pronunciation: RIS-e-DROE-nate
Generic Name: Risedronate
Brand Name: Atelvia

Risedronate Delayed-Release Tablets are used for:

Treating osteoporosis (weak bones) in women who have gone through menopause. It may also be used for other conditions as determined by your doctor.

Risedronate Delayed-Release Tablets are a bisphosphonate. It works by slowing bone loss.

Do NOT use Risedronate Delayed-Release Tablets if:

• you are allergic to any ingredient in Risedronate Delayed-Release Tablets


• you have certain esophagus problems (eg, narrowing, blockage)


• you are unable to stand or sit upright for at least 30 minutes


• you are unable to swallow Risedronate Delayed-Release Tablets whole


• you have low blood calcium levels or severe kidney problems


• you are taking another medicine that contains risedronate

Contact your doctor or health care provider right away if any of these apply to you.

Before using Risedronate Delayed-Release Tablets:

Some medical conditions may interact with Risedronate Delayed-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of stomach or bowel problems (eg, inflammation, ulcer), esophagus problems (eg, narrowing, blockage, heartburn, reflux disease, severe irritation), kidney problems, or if you have difficult or painful swallowing


• if you have low blood vitamin D levels, cancer, anemia, blood clotting problems, an infection, calcium metabolism problems, nutrient absorption problems (eg, malabsorption syndrome), or are unable to take calcium or vitamin D supplements


• if you have poor dental hygiene or other dental problems, or if you will be having a dental procedure (eg, tooth extraction)


• if you smoke or drink alcohol


• if you have had or will be having chemotherapy or radiation treatment


• if you have a mental disorder or other condition that may decrease your ability to follow the dosing instructions for Risedronate Delayed-Release Tablets

Some MEDICINES MAY INTERACT with Risedronate Delayed-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen, naproxen) because the risk of stomach or bowel problems may be increased


• H₂ blockers (eg, ranitidine) or proton pump inhibitors (PPIs) (eg, omeprazole) because they may decrease Risedronate Delayed-Release Tablets's effectiveness


• Corticosteroids (eg, prednisone) because the risk of jawbone problems may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Risedronate Delayed-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Risedronate Delayed-Release Tablets:

Use Risedronate Delayed-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Risedronate Delayed-Release Tablets comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Risedronate Delayed-Release Tablets refilled.


• Take Risedronate Delayed-Release Tablets by mouth in the morning immediately after breakfast. Do NOT take Risedronate Delayed-Release Tablets before breakfast.


• Swallow Risedronate Delayed-Release Tablets whole. Do not break, crush, or chew before swallowing.


• Take Risedronate Delayed-Release Tablets while you are sitting up or standing. Do not lie down or take other medicines for 30 minutes after taking Risedronate Delayed-Release Tablets.


• Take Risedronate Delayed-Release Tablets with at least 4 oz (120 mL) of plain water. Do not take Risedronate Delayed-Release Tablets with mineral water, coffee, tea, milk, or juice.


• Do not take antacids, calcium, certain vitamin products, iron, or products that contain magnesium (eg, certain laxatives) at the same time of day that you take Risedronate Delayed-Release Tablets. Ask your pharmacist if you have questions about how to take any of these products with Risedronate Delayed-Release Tablets.


• If you take H₂ blockers (eg, ranitidine) or PPIs (eg, omeprazole), ask your doctor or pharmacist how to take them with Risedronate Delayed-Release Tablets.


• Risedronate Delayed-Release Tablets are usually taken 1 time each week. Be sure you understand how to take Risedronate Delayed-Release Tablets. Contact your doctor or pharmacist if you have any questions.


• Continue to take Risedronate Delayed-Release Tablets even if you feel well. Do not miss any doses.


• If you miss a dose of Risedronate Delayed-Release Tablets, take 1 tablet on the morning after you remember, then go back to taking Risedronate Delayed-Release Tablets on your regularly scheduled day. Do not take 2 doses on the same day.

Ask your health care provider any questions you may have about how to use Risedronate Delayed-Release Tablets.

Important safety information:

• Risedronate Delayed-Release Tablets may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Risedronate Delayed-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Talk to your doctor before you drink alcohol, smoke, or use other tobacco products while taking Risedronate Delayed-Release Tablets.


• Follow the diet and exercise program given to you by your health care provider. Talk to your doctor about whether you should take a calcium and vitamin D supplement while you take Risedronate Delayed-Release Tablets.


• Talk to your doctor about the use of weight-bearing exercises to help prevent weak bones.


• Certain fractures of the thigh bone (femur) have been reported in patients using bisphosphonates. It is not known if bisphosphonates contributed to the fractures. Contact your doctor right away if you experience hip, thigh, or groin pain. Discuss any questions or concerns with your doctor.


• Risedronate Delayed-Release Tablets may cause jawbone problems in some patients. Your risk may be greater if you have cancer, poor dental hygiene, ill-fitting dentures, or certain other conditions (eg, anemia, blood clotting problems, infections, dental problems). Your risk may also be greater if you have certain dental procedures or you use certain medicines or therapies (eg, chemotherapy, corticosteroids, radiation). Talk to your doctor about having a dental exam before you start to use Risedronate Delayed-Release Tablets. Ask your doctor any questions you may have about dental treatment while you use Risedronate Delayed-Release Tablets.


• Proper dental care is important while you are taking Risedronate Delayed-Release Tablets. Brush and floss your teeth and visit the dentist regularly.


• Certain dental procedures should be avoided if possible while you are taking Risedronate Delayed-Release Tablets. Tell your doctor or dentist that you take Risedronate Delayed-Release Tablets before you receive any medical or dental care, emergency care, or surgery.


• Risedronate Delayed-Release Tablets may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Risedronate Delayed-Release Tablets.


• Lab tests, including bone density and blood calcium levels, may be performed while you take Risedronate Delayed-Release Tablets. These tests may be used to monitor your condition or check for side effects. Your doctor may also want to evaluate you periodically while you take Risedronate Delayed-Release Tablets to assess the need to continue treatment. Be sure to keep all doctor and lab appointments.


• Risedronate Delayed-Release Tablets should not be used in CHILDREN; safety and effectiveness in children have not been confirmed. Risedronate Delayed-Release Tablets are not approved for use in children.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Risedronate Delayed-Release Tablets while you are pregnant. It is not known if Risedronate Delayed-Release Tablets are found in breast milk. Do not breast-feed while taking Risedronate Delayed-Release Tablets.

Possible side effects of Risedronate Delayed-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; mild flu-like symptoms (eg, fever, headache, muscle aches, tiredness); mild joint, back, or muscle pain; mild stomach pain or upset; nausea; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; unusual hoarseness); black, tarry, or bloody stools; chest pain; coughing or vomiting blood; difficult or painful swallowing; mouth sores; new, worsening, or persistent heartburn; severe bone, muscle, or joint pain (especially in the groin, hip, or thigh); severe headache, dizziness, or blurred vision; severe or persistent sore throat or stomach pain; swelling or pain in your jaw; symptoms of low blood calcium (eg, spasms, twitches, or cramps in your muscles; numbness or tingling in your fingers or toes, or around your mouth); unusual eye pain, swelling, redness, or sensitivity to light.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Risedronate side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Do not lie down or try to vomit. Symptoms of overdose may include muscle weakness, spasms, twitching, or cramps; numbness or tingling in the fingers or toes, or around the mouth; seizures; severe heartburn; stomach pain or upset.

Proper storage of Risedronate Delayed-Release Tablets:

Store Risedronate Delayed-Release Tablets at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Risedronate Delayed-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Risedronate Delayed-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Risedronate Delayed-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Risedronate Delayed-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Risedronate resources

• Risedronate Side Effects (in more detail)
• Risedronate Dosage
• Risedronate Use in Pregnancy & Breastfeeding
• Risedronate Drug Interactions
• Risedronate Support Group
• 5 Reviews for Risedronate - Add your own review/rating

Compare Risedronate with other medications

• Osteoporosis
• Paget's Disease
• Prevention of Osteoporosis

Losartan Atid

Losartan Atid may be available in the countries listed below.

Ingredient matches for Losartan Atid

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Atid in the following countries:

• Germany

International Drug Name Search

Bactigram

Bactigram may be available in the countries listed below.

Ingredient matches for Bactigram

Cefaclor

Cefaclor monohydrate (a derivative of Cefaclor) is reported as an ingredient of Bactigram in the following countries:

• Italy

International Drug Name Search

Forzaar

Forzaar may be available in the countries listed below.

Ingredient matches for Forzaar

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Forzaar in the following countries:

• Italy

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Forzaar in the following countries:

• Italy

International Drug Name Search

Batticon

Batticon may be available in the countries listed below.

Ingredient matches for Batticon

Povidone Iodine

Povidone-Iodine is reported as an ingredient of Batticon in the following countries:

• Turkey

International Drug Name Search

Camisan

Camisan may be available in the countries listed below.

Ingredient matches for Camisan

Terbinafine

Terbinafine is reported as an ingredient of Camisan in the following countries:

• Taiwan

International Drug Name Search